Showing results (1-10 of 124) with videos related to
Sort By:
Pageof 13
Psychopharmacology Bulletin|January 1, 1993
Chronic neuroleptic use in manic-depressive illnessM J Sernyak, S W WoodsBiological Psychiatry|February 13, 2001
Consistency of atypical antipsychotic superiority to placebo in recent clinical trialsS W Woods, M Stolar, M J Sernyak, et al.The Journal of Clinical Psychiatry|August 1, 1995
Effects of clozapine on smoking in chronic schizophrenic outpatientsT P George, M J Sernyak, D M Ziedonis, et al.Psychiatric Services (Washington, D.C.)|January 27, 2000
Characteristics of participants and nonparticipants in medication trials for treatment of schizophreniaS W Woods, D M Ziedonis, M J Sernyak, et al.The Journal of Clinical Psychiatry|May 1, 1997
Chronic neuroleptic exposure in bipolar outpatientsM J Sernyak, L S Godleski, R A Griffin, et al.Schizophrenia Research|October 12, 2001
Estimated yield of early detection of prodromal or first episode patients by screening first degree relatives of schizophrenic patientsS W Woods, T J Miller, L Davidson, et al.The American Journal of Psychiatry|January 1, 1994
Neuroleptic exposure following inpatient treatment of acute mania with lithium and neurolepticM J Sernyak, R A Griffin, R M Johnson, et al.Journal of Psychiatry & Neuroscience : JPN|October 10, 2001
Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophreniaE Diaz, H B Levine, M C Sullivan, et al.Journal of Clinical Psychopharmacology|June 9, 1998
Naltrexone augmentation of neuroleptics in schizophreniaM J Sernyak, W M Glazer, G R Heninger, et al.The American Journal of Psychiatry|June 1, 2001
Impact of clozapine on completed suicideM J Sernyak, R Desai, M Stolar, et al.Pageof 13